News
 
Pharmaceuticals Newsletter - May 21 to May 25, 2012
India Infoline News Service/19:38,May 25, 2012
Piramal Healthcare Limited announced today that Phase I clinical trial data for its investigational new drug candidate P1446A-05 will be presented at the Annual Meeting of the American Society for Clinical Oncology (ASCO) being convened in Chicago from June 1-5, 2012.
list India Infoline Weekly Newsletter - May 25, 2012
list Pfizer recalls Advil bottles from distributor centers
list Teva outlines financial estimates for 2012
list Ranbaxy hires advisers for resolving consent decree with USFDA

Calendar

May-2012
M T W T F S S
21 22 23 24 25 26 27
Economic Events
list Corporate Service Price (YoY)
list Hometrack Housing Survey (MoM)
Results
list No result today
IPO
listNo IPO today
 
Skip Navigation Links.

Oxides & Specialities reports net loss of Rs 0.11 crore in the December 2011 quarter
Capital Market / 18:28 , Feb 11, 2012

No sales reported during the quarter

Oxides & Specialities reported net loss of Rs 0.11 crore in the quarter ended December 2011 as against net loss of Rs 0.48 crore during the previous quarter ended December 2010. There were no sales reported in the quarter ended December 2011 and during the previous quarter ended December 2010.
 



Rate This Article Rate 1 Rate 2 Rate 3 Rate 4 Rate 5